Produkty 53452-34-9

CAS 53452-34-9 występuje w naszej ofercie pod nazwami: Creticoside C, Creticoside C, ≥95%. Oferty producentów: Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, Get quote.

Creticoside C
Biosynth, MedChemExpress
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
Zobacz produkt
Creticoside C, ≥95%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 5234,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,3R,4S,5S,6R)-2-[[(1R,3R,4R,7R,9S,10R,13R,14R)-3,14-dihydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol (CAS 53452-34-9) to związek chemiczny o wzorze sumarycznym C26H44O8 i masie molowej 484.6 g/mol. Nazwa systematyczna IUPAC: (2R,3R,4S,5S,6R)-2-[[(1R,3R,4R,7R,9S,10R,13R,14R)-3,14-dihydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol. InChIKey: RGKNTHMUHXNDHJ-UBQJNZDZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H44O8
Masa molowa484.6 g/mol
Nazwa IUPAC(2R,3R,4S,5S,6R)-2-[[(1R,3R,4R,7R,9S,10R,13R,14R)-3,14-dihydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
InChIKeyRGKNTHMUHXNDHJ-UBQJNZDZSA-N
SMILESC[C@@]12C[C@@H](CC([C@H]1[C@@H](C[C@]34[C@H]2CC[C@H](C3)[C@](C4)(C)O)O)(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Creticoside C, orb1682887, 6|A,16-Dihydroxykauran-2|A-yl |A-D-glucopyranoside, I(2)-D-Glucopyranoside, (2I(2),6I(2))-6,16-dihydroxykauran-2-yl
Powiązane formy tego związku
(2R,3R,4R,5S,6R)-2-[[(1R,3R,4R,7R,9S,10R,13R,14R)-3,14-dihydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
Izomery (ten sam wzór sumaryczny)
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid C26H44O8
(2R,3R,4S,5S,6R)-2-[[(2R,4aS,4bR,7S,10aS)-7-[(1R)-1,2-dihydroxyethyl]-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthren-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
2-[(E)-5-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
2-[(6,14-dihydroxy-5,5,9-trimethyl-14-tetracyclo[11.2.1.01,10.04,9]hexadecanyl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
(2R,3R,4S,5S,6R)-2-[[(1R,4aS,5R,8aS)-5-[(Z)-5-hydroxy-3-(hydroxymethyl)pent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
(2R,3R,4R,5S,6R)-2-[[(1S,4S,5R,7S,9S,10R,13R,14R)-14-hydroxy-5-(hydroxymethyl)-5,9,14-trimethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8